In a groundbreaking study, researchers have introduced a non-invasive method to predict stroke risk using a 'vascular fingerprint' identified in the retina, suggesting revolutionary potential for medical diagnostics. The method is detailed in the journal Heart, demonstrating that retinal
Imagine a world where getting vaccinated no longer means facing a needle and syringe, but instead, involves a simple patch applied to the skin. This prospect is rapidly becoming a reality thanks to the innovative work of the University of Queensland (UQ) and Brisbane-based biotech company Vaxxas.
The pharmaceutical industry is on the brink of significant transformation, driven by advancements in oncology, artificial intelligence (AI), and evolving policy landscapes. As we look towards 2025 and beyond, these changes promise to revolutionize drug development, clinical trials, and patient
Precision oncology is revolutionizing cancer treatment by tailoring medical care based on the genetic makeup of a patient's tumor. However, significant disparities exist in the effectiveness and availability of these treatments among patients of different ancestries. This article delves into
NEC Corporation and Biomy, Inc. have announced a groundbreaking partnership aimed at revolutionizing digital pathology through the integration of artificial intelligence (AI) and deep learning (DL). This collaboration, formalized in a recent Memorandum of Understanding (MoU), seeks to enhance
Groundbreaking research conducted by a collaborative team from Mount Sinai and Memorial Sloan Kettering Cancer Center has unveiled a novel mechanism by which monoamine neurotransmitters, specifically serotonin, dopamine, and histamine, regulate brain physiology and behavior. This research
